Air pollution alters immune function through multiple pathways, and mounting evidence links those alterations to weaker responses after vaccination. Pollutants such as fine particulate matter, nitrogen dioxide, and ozone trigger systemic inflammation and oxidative stress, which can blunt the coordination of innate and adaptive immune responses that vaccines rely on. The magnitude of the effect varies with pollutant type, exposure timing, age, and underlying health.
Biological mechanisms
Airborne particles and gases interact with respiratory epithelium and immune cells, impairing antigen presentation by dendritic cells and skewing T cell differentiation away from protective responses. Jonathan Grigg Queen Mary University of London has reviewed how pollution-driven airway inflammation can reduce mucosal immunity and alter systemic signaling. Andrea Baccarelli Columbia University Mailman School of Public Health has documented pollution-associated changes in DNA methylation and other epigenetic modifications that affect immune gene regulation. Together these mechanisms can reduce the generation of high-affinity antibodies and memory cells after vaccination, particularly when exposure occurs repeatedly or during critical windows such as infancy.
Epidemiological evidence and consequences
Observational studies report associations between higher ambient pollution and lower post-vaccination antibody titers or reduced vaccine effectiveness for respiratory vaccines in different populations. Public health authorities such as the World Health Organization highlight that environmental exposures modulate host susceptibility to infectious disease, which can translate into more frequent breakthrough infections or lower herd immunity in polluted areas. Causality is still being clarified in long-term, well-controlled human studies, and findings differ by vaccine type and population group.
The real-world consequences are social and territorial as well as biological. Urban neighborhoods and low-income communities that face disproportionate pollution burdens may also experience reduced benefits from vaccination programs, compounding environmental injustice. For public health planning this means vaccination strategies should consider local exposure profiles, and policymakers should prioritize pollution reduction to protect vaccine-induced immunity.
Reducing ambient pollutants, targeting outreach to highly exposed populations, and investing in mechanistic and longitudinal studies will clarify the extent of the effect and guide mitigation. Because individual and community-level factors interact with exposure, both biomedical research and environmental policy are needed to preserve vaccine performance across diverse settings.